Earnings per Share (EPS) is expected to be -$0.03, marking a 25$205.75 million, indicating a 3.39% increase from the previous year.Tilray's stock has experienced a 38.4% surge over the past month, outperforming the Medical sector and the S&P 500.Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent player in the cannabis industry, known for its diverse product offerings and strategic acquisitions. The company has expanded its portfolio beyond canna ...